MRK | Merck 78.17 -0.67 (-0.85%)
Category: Pharmaceutical company
Industry: Drug Manufacturers - Major Quick infos Headquarters: Kenilworth, New Jersey, United States Trade prices Volume: 2.6M Market Cap: 201.91B Prev closed: 79.21 Open: 79.26 High: 80.62 Low: 79.26 52 week low: 65.25 52 week high: 92.64 Dividends: Next ER: October 27, 2020 Before Market Opens
About the Company Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American pharmaceutical company and one of the largest pharmaceutical companies in the world.
Earnings History Date EPS / Forecast Revenue / Forecast October 27, 2020 1.74 / 1.4412.55B / 12.19BBeat! July 31, 2020 1.37 / 1.0610.87B / 10.4BBeat! April 28, 2020 1.5 / 1.3412.06B / 11.48BBeat! February 5, 2020 1.16 / 1.1511.87B / 11.98BOctober 29, 2019 1.51 / 1.2412.4B / 11.64BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Oct 27, 2020 77.99 79.13 80.18
77.99
11.68M -1.08% Oct 26, 2020 78.84 79.26 79.74
78.26
8.70M -1.24% Oct 23, 2020 79.83 79.26 80.62
79.26
6.97M 0.78% Oct 22, 2020 79.21 78.27 79.42
78.24
5.80M 1.46% Oct 21, 2020 78.07 78.26 78.82
78.06
9.25M -0.26% Oct 20, 2020 78.27 78.82 78.92
78.10
10.63M -0.51% Oct 19, 2020 78.67 80.11 80.44
78.34
8.22M -1.45% Oct 16, 2020 79.83 79.30 80.30
79.11
7.54M 0.97% Oct 15, 2020 79.06 79.81 79.81
78.78
8.73M -1.8% Oct 14, 2020 80.51 80.87 80.87
80.08
8.75M -0.25% view more
NYSE - New York Stock Exchange
More profiles and info about the company ISIN: US58933Y1055 CUSIP: 58933Y105 Founded:1891, New York, United States Employees:68,000 News
Merck up 2% premarket on Q3 beat; FY20 non-GAAP EPS guidance raised seekingalpha.com Oct 27, 2020 7:40 pm Merck EPS beats by $0.31, beats on revenue seekingalpha.com Oct 27, 2020 6:46 pm These 2 Pharmas Have Made Their Pipelines a Competitive Advantage fool.com Oct 27, 2020 7:05 am
Merck Announces Third-Quarter 2020 Financial Results finance.yahoo.com Oct 27, 2020 6:45 am Merck Q3 2020 Earnings Preview seekingalpha.com Oct 27, 2020 1:58 am
Doctor of COVID-19 vaccine: Its unlikely well see the data before the election finance.yahoo.com Oct 26, 2020 2:46 pm
Merck Presents Three-Year Survival Data for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy and Updated Phase 1/2 Data for Investigational Quavonlimab (MK-1308) in Combination With KEYTRUDA in Advanced NonSmall Cell Lung Cancer finance.yahoo.com Oct 26, 2020 2:00 pm Why Seattle Genetics Stock Jumped 24% in September fool.com Oct 26, 2020 9:44 am Time to Buy Beat-Down Merck & Co. Inc. (MRK) Stock? Here is the INSIGHT investchronicle.com Oct 22, 2020 4:44 pm
Merck & Co., (MRK): Stock Roundup | Armenian American ... reporter.am Oct 22, 2020 4:44 pm
Glaxo Vaccines Target Another Viral Threat barrons.com Oct 22, 2020 12:04 pm
Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts finance.yahoo.com Oct 22, 2020 9:10 am MRK Stock Rises As Pneumococcal Vaccine Candidate ... investors.com Oct 21, 2020 4:44 pm
Merck Posts Positive Data For Pneumococcal Vaccine Candidate, Eyes Approval finance.yahoo.com Oct 20, 2020 7:10 pm
Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck's Investigational 15-valent Pneumococcal Conjugate Vaccine finance.yahoo.com Oct 20, 2020 9:10 am Advaxis down 12% despite ADXS-503 shows sustained tumor control in mid-stage lung cancer trial seekingalpha.com Oct 26, 2020 8:46 pm
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger finance.yahoo.com Oct 26, 2020 8:17 am
Health Canada Approves KEYTRUDA® (pembrolizumab) as First-line Treatment for Patients with Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma finance.yahoo.com Oct 26, 2020 7:00 am MRK Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Sep 14, 2020 0.61 Oct 7, 2020 Jun 12, 2020 0.61 Jul 7, 2020 Mar 13, 2020 0.61 Apr 7, 2020 Dec 13, 2019 0.61 Jan 8, 2020 Sep 13, 2019 0.55 Oct 7, 2019 view more
Key Persons Talk about Merck below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: merck.com Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
